Neurocrine Biosciences
NBIX
#1452
Rank
NZ$26.36 B
Marketcap
NZ$259.39
Share price
-0.19%
Change (1 day)
3.71%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company